Robert L. Vitti

1 Patent

• US122800932025

  Use of a VEGF Receptor-based Fusion Protein Antagonist to Treat Nonproliferative Diabetic Retinopathy

  REGENRON PHARMACEUTICALS, Inc.

  0 cites